Pierluigi Navarra Selected Research

Vitamin D Deficiency

1/2022

Extended-release calcifediol in stage 3-4 chronic kidney disease: a new therapy for the treatment of secondary hyperparathyroidism associated with hypovitaminosis D.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Pierluigi Navarra Research Topics

Disease

25	Neoplasms (Cancer) 06/2023 - 03/2002
8	Glioblastoma (Glioblastoma Multiforme) 06/2023 - 10/2002
7	Glioma (Gliomas) 01/2023 - 10/2002
7	Pain (Aches) 11/2018 - 03/2009
6	Migraine Disorders (Migraine) 10/2020 - 08/2009
5	Melanoma (Melanoma, Malignant) 01/2022 - 04/2008
5	Infections 07/2020 - 01/2012
4	Hypersensitivity (Allergy) 05/2016 - 04/2011
3	Breast Neoplasms (Breast Cancer) 01/2023 - 07/2003
3	Brain Neoplasms (Brain Tumor) 01/2023 - 03/2004
3	Critical Illness (Critically Ill) 10/2020 - 01/2015
3	Multiple Sclerosis 05/2019 - 01/2002
3	Inflammation (Inflammations) 01/2017 - 06/2008
3	Hypoxia (Hypoxemia) 11/2009 - 12/2004
2	Hyperalgesia 11/2023 - 03/2013
2	Prostatic Neoplasms (Prostate Cancer) 01/2023 - 06/2008
2	Squamous Cell Carcinoma of Head and Neck 01/2023 - 07/2006
2	Ventilator-Associated Pneumonia 01/2023 - 01/2015
2	Encephalitis (Encephalitis, Rasmussen) 01/2023 - 11/2009
2	Macular Degeneration (Age-Related Maculopathy) 11/2020 - 01/2020
2	Chronic Pain 07/2020 - 01/2015
2	Neuroblastoma 10/2019 - 09/2015
2	Alzheimer Disease (Alzheimer's Disease) 05/2019 - 10/2006
2	Nervous System Diseases (Neurological Disorders) 01/2019 - 01/2012
2	Disease Progression 03/2013 - 02/2013
2	Bipolar Disorder (Manic Depressive Psychosis) 08/2009 - 11/2004
2	Endometrial Neoplasms (Endometrial Cancer) 06/2009 - 02/2006
2	Depressive Disorder (Melancholia) 10/2006 - 02/2005
2	Fever (Fevers) 06/2006 - 03/2005
2	Colonic Neoplasms (Colon Cancer) 01/2005 - 12/2004
2	Adenocarcinoma 07/2003 - 03/2002
1	Adrenocortical Carcinoma 01/2023
1	Carcinoma (Carcinomatosis) 01/2023
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2023
1	Intestinal helminthiasis 01/2023
1	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 01/2023
1	Head and Neck Neoplasms (Head and Neck Cancer) 01/2023
1	Secondary Hyperparathyroidism 01/2022

Drug/Important Bio-Agent (IBA)

8	Proteins (Proteins, Gene)FDA Link 11/2020 - 12/2004
6	Monoclonal AntibodiesIBA 01/2022 - 01/2012
5	Calcitonin Gene-Related PeptideIBA 10/2020 - 08/2009
5	Peptides (Polypeptides)IBA 01/2019 - 11/2004
5	Corticotropin-Releasing HormoneIBA 09/2015 - 02/2005
4	Sirolimus (Rapamycin)FDA Link 06/2023 - 03/2013
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2020 - 12/2004
4	abacavir (Ziagen)FDA Link 05/2016 - 04/2011
4	Corticotropin-Releasing Hormone Receptors (Corticotropin Releasing-Hormone Receptor)IBA 09/2015 - 03/2002
4	Temozolomide (Temodar)FDA LinkGeneric 06/2008 - 10/2002
4	ProstaglandinsIBA 06/2006 - 10/2003
3	IpilimumabIBA 01/2022 - 01/2012
3	HLA-B57 antigenIBA 05/2016 - 04/2011
3	Messenger RNA (mRNA)IBA 09/2015 - 06/2006
3	Phosphotransferases (Kinase)IBA 01/2015 - 03/2013
3	Estrogens (Estrogen)FDA Link 08/2014 - 07/2003
3	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 03/2009 - 10/2003
3	Valproic Acid (Depakote)FDA LinkGeneric 06/2008 - 07/2003
3	Antineoplastic Agents (Antineoplastics)IBA 06/2008 - 03/2004
2	Remifentanil (Ultiva)FDA Link 11/2023 - 01/2023
2	Drug CombinationsIBA 01/2023 - 10/2002
2	NivolumabIBA 01/2022 - 01/2022
2	Programmed Cell Death 1 ReceptorIBA 01/2022 - 01/2022
2	Immune Checkpoint InhibitorsIBA 01/2022 - 01/2022
2	Conditioned Culture MediaIBA 11/2020 - 07/2014
2	Retinaldehyde (Retinal)IBA 11/2020 - 05/2019
2	gamma-glutamylaminomethylsulfonic acid (GAMS)IBA 11/2020 - 01/2017
2	Tigecycline (Tygacil)FDA Link 10/2020 - 07/2020
2	Bevacizumab (Avastin)FDA Link 01/2020 - 01/2020
2	LigandsIBA 01/2020 - 01/2019
2	Urea (Carbamide)FDA LinkGeneric 10/2019 - 08/2013
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 10/2019 - 09/2019
2	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 09/2019 - 03/2005
2	Chemokine ReceptorsIBA 09/2017 - 01/2012
2	Maraviroc FDA Link 09/2017 - 01/2012
2	Interleukin-10 (Interleukin 10)IBA 09/2017 - 07/2014
2	TOR Serine-Threonine KinasesIBA 01/2015 - 07/2014
2	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2014 - 03/2009
2	Glucose (Dextrose)FDA LinkGeneric 08/2013 - 11/2009
2	Atazanavir Sulfate (Reyataz)FDA Link 06/2013 - 04/2011
2	Analgesics (Analgesic Drugs)IBA 01/2012 - 03/2009
2	flupirtineIBA 01/2012 - 01/2011
2	Formaldehyde (Formol)FDA Link 01/2011 - 03/2009
2	Antidepressive Agents (Antidepressants)IBA 10/2006 - 02/2005
2	Neurotransmitter Agents (Neurotransmitter)IBA 10/2006 - 02/2005
2	Endothelin-1 (Endothelin 1)IBA 06/2006 - 03/2005
2	Celecoxib (Celebrex)FDA Link 03/2005 - 10/2003
2	Prostaglandins EIBA 01/2005 - 12/2004
2	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 12/2004 - 10/2003
1	Immunosuppressive Agents (Immunosuppressants)IBA 06/2023
1	sapanisertibIBA 06/2023
1	Mechanistic Target of Rapamycin Complex 1IBA 06/2023
1	Mebendazole (Anti-Worm)FDA Link 01/2023
1	benzimidazoleIBA 01/2023
1	Antiparasitic Agents (Antiparasitics)IBA 01/2023
1	Colistin (Coly-Mycin)FDA Link 01/2023
1	hydroxide ionIBA 01/2022
1	Vitamin D FDA LinkGeneric 01/2022
1	Calcifediol (Calcidiol)FDA Link 01/2022

Therapy/Procedure

10	Therapeutics 06/2023 - 12/2004
4	Drug Therapy (Chemotherapy) 01/2023 - 03/2004
1	Radiotherapy 01/2023